Clinical Study on the Treatment of Hyperlipidemia Patients with Phlegm-dampness Retention by Xuezhikang Capsules
Bing Liu
Abstract
Bing Liu
Abstract
Objective: To study the clinical efficacy and adverse reaction of Xuezhikang capsules on the treatment of hyperlipidemia patients with phlegm-dampness retention.Methods: 45 patients were divided into one treatment control and one control group randomly and double-blindly.30 patients in the treatment group were treated with Xuezhikang capsules while 15 patients in the control group were treated with placebo.8 weeks was a course of treatment.The clinical efficacy of the two groups was compared after the treatment.Results: The comparison of the serum lipid efficacy,the scores of TCM symptom and the traditional Chinese medicine syndromes of the two groups showed a significant difference(P0.05).Conclusion: Xuezhikang capsules have effect on the treatment of the hyperlipidemia patients,improve their clinical symptoms and are safe and effective cholesterol lowering agents.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the clinical efficacy and adverse reaction of Xuezhikang capsules on the treatment of hyperlipidemia patients with phlegm-dampness retention.Methods: 45 patients were divided into one treatment control and one control group randomly and double-blindly.30 patients in the treatment group were treated with Xuezhikang capsules while 15 patients in the control group were treated with placebo.8 weeks was a course of treatment.The clinical efficacy of the two groups was compared after the treatment.Results: The comparison of the serum lipid efficacy,the scores of TCM symptom and the traditional Chinese medicine syndromes of the two groups showed a significant difference(P0.05).Conclusion: Xuezhikang capsules have effect on the treatment of the hyperlipidemia patients,improve their clinical symptoms and are safe and effective cholesterol lowering agents.
Key concepts: Medicine, Hyperlipidemia, Phlegm, Clinical efficacy, Placebo, Internal medicine, Adverse effect, Traditional Chinese medicine